Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition episode artwork

EPISODE · Dec 19, 2023 · 1H 5M

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

from Oncology Today with Dr Neil Love

Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Dec 19, 2023

Embed this episode

Ready to play

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

0:00 1:05:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 1 hour and 5 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on December 19, 2023.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!